Articles, guides, and regulatory updates from our community.
New research suggests thymosin alpha-1 may help restore anti-tumor immunity after chemotherapy by activating dendritic cells. Learn what the study found.
By Peptide Association Research Team
A deep dive into thymosin alpha-1 — the endogenous thymic peptide with decades of clinical research supporting its role in immune modulation, viral infections, and as an immunotherapy adjunct.
By Peptide Association Editorial Team